Zonare Medical Systems raised $34 million in equity funding earlier this month to put toward the development of a next-generation ultrasound platform. The company's Zone Sonography technology is being groomed first for general imaging and ob/gyn.
Zonare Medical Systems raised $34 million in equity funding earlier this month to put toward the development of a next-generation ultrasound platform. The company's Zone Sonography technology is being groomed first for general imaging and ob/gyn. Subsequent developments will address cardiology and 4D imaging. Previous and new investors include Montagu Newhall Associates, Kaiser Permanente Ventures, Earlybird Venture Capital, and Siemens Venture Capital.
The company is being directed by new president and CEO Donald J. Southard, who joined the firm last month after serving as president of Datascope's $160 million patient monitoring business.
Mammography Study Compares False Positives Between AI and Radiologists in DBT Screening
May 8th 2025For DBT breast cancer screening, 47 percent of radiologist-only flagged false positives involved mass presentations whereas 40 percent of AI-only flagged false positive cases involved benign calcifications, according to research presented at the recent American Roentgen Ray Society (ARRS) conference.